AUG 11, 2026 · JOURNAL ARTICLE
Dynamic changes in ER, PR, HER2, Ki-67, and AR before and after neoadjuvant therapy in breast cancer and their clinicopathological significance: a single-center real-world study
BMC Cancer
Real-world retrospective analysis of 644 patients showing biomarker dynamics after neoadjuvant therapy with clear statistical associations and pathological outcomes, but limited by single-center design and lack of prospective validation or clinical outcome follow-up.
Reported
Sample size644
ER conversion rate13.4%
PR conversion rate17.7%